Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apices Soluciones
Pinto, Comunidad de Madrid, Spainapices.es ↗
- Ownership
- Private
- Employees
- ~73
- Development stage
- Other
01
Overview
Apices Soluciones is a full-service CRO with over 41 clinical trials, experience from Phase I to Phase IV, and particular recent activity in oncology. Its current pipeline includes projects such as a Phase 3 study for atezolizumab (PDL1 inhibitor) in metastatic carcinoma to the uterine cervix and a program called AloCelyvir for recurrent medulloblastoma
- Therapeutic areas
- OncologyImmunologyInfectious DiseasesHematologyNeurologyEndocrinology
- Modalities
- Monoclonal antibodyMesenchymal stem cell therapy
- Industry
- Contract Research Organization
02
Partnerships
No specific named partnerships disclosed in sources
Beyond the preview
Go deeper on Apices Soluciones.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Apices Soluciones.